Mereo BioPharma Group (MREO) Earnings Date, Estimates & Call Transcripts $2.19 +0.01 (+0.46%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$2.22 +0.04 (+1.60%) As of 05/28/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mereo BioPharma Group Earnings Summary Mereo BioPharma Group issued Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.02, which missed the consensus estimate of -$0.01 by $0.01. With a trailing EPS of -$0.07, Mereo BioPharma Group's earnings are expected to decrease next year, from ($0.03) to ($0.04) per share. Upcoming Q2 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (May. 13) -$0.01 Actual EPS (May. 13) -$0.02 Missed By -$0.01 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)MREO Upcoming EarningsMereo BioPharma Group's next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Powered by Get Mereo BioPharma Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mereo BioPharma Group and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMREO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Mereo BioPharma Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$0.07$0.07$0.07Q2 20251-$0.01-$0.01-$0.01Q3 20251$0.10$0.10$0.10Q4 20251$0.05$0.05$0.05 Mereo BioPharma Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/13/2025Q1 2025-$0.01-$0.02 -$0.01-$0.02$72.50M-3/26/2025Q4 2024$0.02-$0.01 -$0.03-$0.01$72.50M-5/15/2024Q1 2024--$0.01 -$0.01-$0.01--9/7/2023H1 2024-$0.02-$0.02---- Mereo BioPharma Group Earnings - Frequently Asked Questions When is Mereo BioPharma Group's earnings date? Mereo BioPharma Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on MREO's earnings history. Did Mereo BioPharma Group beat their earnings estimates last quarter? In the previous quarter, Mereo BioPharma Group (NASDAQ:MREO) missed the analysts' consensus estimate of ($0.01) by $0.01 with a reported earnings per share (EPS) of ($0.02). Learn more on analysts' earnings estimate vs. MREO's actual earnings. How much revenue does Mereo BioPharma Group generate each year? Mereo BioPharma Group (NASDAQ:MREO) has a recorded annual revenue of $1 million. How much profit does Mereo BioPharma Group generate each year? Mereo BioPharma Group (NASDAQ:MREO) has a recorded net income of -$29.47 million. MREO has generated -$0.07 earnings per share over the last four quarters. What is Mereo BioPharma Group's EPS forecast for next year? Mereo BioPharma Group's earnings are expected to decrease from ($0.03) per share to ($0.04) per share in the next year. More Earnings Resources from MarketBeat Related Companies Structure Therapeutics Earnings Results Janux Therapeutics Earnings Results ARS Pharmaceuticals Earnings Results Adaptive Biotechnologies Earnings Results Vera Therapeutics Earnings Results Dyne Therapeutics Earnings Results ANI Pharmaceuticals Earnings Results Ocular Therapeutix Earnings Results Calliditas Therapeutics AB (publ) Earnings Results Amphastar Pharmaceuticals Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again? This page (NASDAQ:MREO) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MREO Stock Free MREO Stock Alerts